“Life is about finding out what you are good at and having fun with it”
Dr. Pei received a BS degree in chemistry from Wuhan University, China and a PhD in organic chemistry from University of California, Berkeley. Following a Damon Runyon-Walter Winchell postdoctoral fellowship at Harvard Medical School, he started his independent career at The Ohio State University in 1995 and is currently a Professor of Chemistry and Biochemistry. He has been the CBIP Director at Ohio State since 2003. He is the scientific founder of CycloPorters, a biopharmaceutical company which develops peptide and protein drugs against challenging targets.
Dr. Pei’s research interest is in the chemical biology of eukaryotic cell signaling and the development of macrocyclic molecules as inhibitors of protein-protein interactions and other signaling proteins. His group has developed a general methodology for combinatorial synthesis and screening of large cyclic peptide libraries for binding to proteins of interest and discovered a family of cyclic cell-penetrating peptides for efficient intracellular delivery of therapeutic agents and chemical probes.